<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03941938</url>
  </required_header>
  <id_info>
    <org_study_id>131/2019</org_study_id>
    <nct_id>NCT03941938</nct_id>
  </id_info>
  <brief_title>ReAL Trial (Rectal Anastomotic seaL)</brief_title>
  <acronym>ReAL</acronym>
  <official_title>Prevention of Anastomotic Leak in Colorectal Surgery by Glue Reinforcement. A Prospective Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Societa Italiana di Chirurgia ColoRettale</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Societa Italiana di Chirurgia ColoRettale</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The problem of anastomotic leak is particularly relevant in rectal surgery. Many risk factors&#xD;
      have been recognized in the onset of this complication. Preventing the anastomotic leak can&#xD;
      bring benefits to the patient and the health system.&#xD;
&#xD;
      Several attempts have been proposed to reduce the risk of anastomotic leakage in rectal&#xD;
      cancer surgery including suture protection with omental flap and external suture&#xD;
      reinforcement by biological glue or mesh.&#xD;
&#xD;
      Cyanoacrylate (Glubran 2Â®) is a synthetic glue with sealing, adhesive and hemostatic&#xD;
      properties widely used in surgery. The sealing effect creates an antiseptic barrier against&#xD;
      bacteria.&#xD;
&#xD;
      The hypothesis is that the application of nebulized cyanoacrylate to the colo-rectal&#xD;
      anastomosis in open or laparoscopic/robotic rectal surgery can prevent the leakage&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colorectal cancer (CRC) is the second most common cause of cancer-related death in male and&#xD;
      the third in females in Western Countries accounting for more than 500,000 deaths in 2013&#xD;
      worldwide.&#xD;
&#xD;
      One of the most worrying postoperative complication in colorectal surgery is the anastomotic&#xD;
      leak which can occur in about 10-15% of the cases.&#xD;
&#xD;
      This complication severely impact clinical outcomes with increased risk of death or permanent&#xD;
      stoma, higher risk of local recurrence) and relevant increase in hospital costs (length of&#xD;
      hospital stay, admission to intensive care, re-interventions).&#xD;
&#xD;
      The problem of anastomotic leak is particularly relevant in rectal surgery. The more distal&#xD;
      the anastomosis, the higher the likelihood of failure, with resection of a distal rectal&#xD;
      cancer having almost a five-fold increased risk of anastomotic leak compared with resection&#xD;
      for colon cancer.&#xD;
&#xD;
      In fact, anastomotic Leakage (AL) is the most severe complication after Low anterior&#xD;
      resection of rectum for cancer, occurring between 3 and 24 % of patients.&#xD;
&#xD;
      Many risk factors have been recognized in the onset of this complication, including gender&#xD;
      (male patient have a higher anastomotic leak rate), malnutrition, obesity an diabet, american&#xD;
      society anesthesiologists (ASA) score, tobacco use, cardiovascular disease,&#xD;
      immunosuppression, use of NSAID, preoperative pelvis radiation.&#xD;
&#xD;
      Other intraoperative risk factors considered are the splenic flexure mobilization with&#xD;
      proximal ligation of the inferior mesenteric artery (IMA), positive intraoperative Air-Leak&#xD;
      Test and the perfusion of the anastomosis.&#xD;
&#xD;
      Temporary fecal diversion has also been suggested (although a diverting stoma mitigates the&#xD;
      clinical consequences of an anastomotic leak but does not prevent it.&#xD;
&#xD;
      Other intraoperative technical factors include the use of single or double stapled&#xD;
      anastomotic techniques, with or without transanal reinforcing sutures.&#xD;
&#xD;
      Therefore, preventing the anastomotic leak can bring benefits to the patient and the health&#xD;
      system.&#xD;
&#xD;
      All the risk factors described above represent the rationale that justifies the use of&#xD;
      intraoperative procedures to prevent the anastomotic leak, such as additional manual stiches&#xD;
      to the mechanical suture and / or patches of collagen (proper reinforcement or buttressing)&#xD;
      or of sealants.&#xD;
&#xD;
      Several attempts have been proposed to reduce the risk of AL in rectal cancer surgery&#xD;
      including suture protection with omental flap and external suture reinforcement by biological&#xD;
      glue or mesh.&#xD;
&#xD;
      Some Authors have reported good results of reinforcement of the colon anastomosis with&#xD;
      cyanoacrylate glue. in a porcine model.&#xD;
&#xD;
      Cyanoacrylate is a synthetic glue with sealing, adhesive and haemostatic properties widely&#xD;
      used in surgery. Furthermore the sealing effect creates an antiseptic barrier against&#xD;
      bacteria.&#xD;
&#xD;
      Several clinical studies have described the utility of cyanoacrylate glue mainly in vascular&#xD;
      surgery, urology and bariatric surgery.&#xD;
&#xD;
      Considering its mechanical, physical, biological properties and its safety, cyanoacrylate&#xD;
      glue could facilitate the healing of the colorectal anastomosis reducing leak rate, without&#xD;
      negative effects on perfusion.&#xD;
&#xD;
      The hypothesis is that the application of nebulized cyanoacrylate to the colo-rectal&#xD;
      anastomosis in open or laparoscopic/robotic rectal surgery can prevent the leakage&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2, 2019</start_date>
  <completion_date type="Anticipated">July 2, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anastomotic leak</measure>
    <time_frame>30 days</time_frame>
    <description>leakage of the colorectal anastomosis clinically proven or with two sides X-ray</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>the amount of bleeding during the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>30 days</time_frame>
    <description>purulent discharge from the wound with positive culture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>30 days</time_frame>
    <description>complications after the operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Cyanoacrylate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the anastomotic reinforcement with nebulized cyanoacrylate glue using the special short catheter device for open surgery or the laparoscopic catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No reinforcement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No reinforcement will be applied on the anastomosis line</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cyanoacrylate reinforcement</intervention_name>
    <description>Anastomosis Reinforcement with with nebulization of 1cc of glue on the anastomosis line</description>
    <arm_group_label>Cyanoacrylate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No reinforcement</intervention_name>
    <description>Nothing applied on the anastomosis line</description>
    <arm_group_label>No reinforcement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Resectable, histologically proven primary adenocarcinoma of the High-medium rectum&#xD;
             without internal and/or external sphincter muscle involvement.&#xD;
&#xD;
          -  Distal margin of the tumor at least 8 cm form the anal verge&#xD;
&#xD;
          -  Staged as follows prior to neoadjuvant chemoradiation: Stage T2 - T4 at MRI&#xD;
&#xD;
          -  Patient classified T3-T4 will undergo neoadjuvant chemoradiation if the cancer is&#xD;
             located in the extraperitoneal rectum&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Squamous cell carcinoma&#xD;
&#xD;
          -  Adenocarcinoma Stage T1,&#xD;
&#xD;
          -  T4 with one of the following: with pelvic side wall involvement, requiring sacrectomy,&#xD;
             requiring prostatectomy (partial or total)&#xD;
&#xD;
          -  Unresectable primary rectal cancer or Inability to complete R0 resection.&#xD;
&#xD;
          -  Rectal cancer under 8 cm from the anal verge requiring colo-anal or ultra low rectal&#xD;
             anastomosis&#xD;
&#xD;
          -  Recurrent rectal cancer&#xD;
&#xD;
          -  Previous pelvic malignancy&#xD;
&#xD;
          -  Inability to sign the informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donato Altomare, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Societa Italiana di Chirurgia ColoRettale</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arcangelo Picciariello, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Societa Italiana di Chirurgia ColoRettale</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Donato Altomare, MD</last_name>
    <phone>+39 3397593066</phone>
    <email>donatofrancesco.altomare@uniba.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arcangelo Picciariello, MD</last_name>
    <phone>+393492185104</phone>
    <email>arcangelopicciariello@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept of Emergency and Organ transplantation - University of Bari</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donato F Altomare, Prof</last_name>
      <email>donatofrancesco.altomare@uniba.it</email>
    </contact>
    <investigator>
      <last_name>Donato Altomare, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arcangelo Picciariello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Thomas MS, Margolin DA. Management of Colorectal Anastomotic Leak. Clin Colon Rectal Surg. 2016 Jun;29(2):138-44. doi: 10.1055/s-0036-1580630. Review.</citation>
    <PMID>27247539</PMID>
  </results_reference>
  <results_reference>
    <citation>de la Portilla F, Zbar AP, Rada R, Vega J, Cisneros N, Maldonado VH, Utrera A, Espinosa E. Bioabsorbable staple-line reinforcement to reduce staple-line bleeding in the transection of mesenteric vessels during laparoscopic colorectal resection: a pilot study. Tech Coloproctol. 2006 Dec;10(4):335-8. Epub 2006 Nov 27. Erratum in: Tech Coloproctol. 2009 Mar;13(1):103.</citation>
    <PMID>17115313</PMID>
  </results_reference>
  <results_reference>
    <citation>Wiggins T, Markar SR, Arya S, Hanna GB. Anastomotic reinforcement with omentoplasty following gastrointestinal anastomosis: A systematic review and meta-analysis. Surg Oncol. 2015 Sep;24(3):181-6. doi: 10.1016/j.suronc.2015.06.011. Epub 2015 Jun 17. Review.</citation>
    <PMID>26116395</PMID>
  </results_reference>
  <results_reference>
    <citation>Boersema GSA, Vennix S, Wu Z, Te Lintel Hekkert M, Duncker DGM, Lam KH, Menon AG, Kleinrensink GJ, Lange JF. Reinforcement of the colon anastomosis with cyanoacrylate glue: a porcine model. J Surg Res. 2017 Sep;217:84-91. doi: 10.1016/j.jss.2017.05.001. Epub 2017 May 10.</citation>
    <PMID>28595813</PMID>
  </results_reference>
  <results_reference>
    <citation>Montanaro L, Arciola CR, Cenni E, Ciapetti G, Savioli F, Filippini F, Barsanti LA. Cytotoxicity, blood compatibility and antimicrobial activity of two cyanoacrylate glues for surgical use. Biomaterials. 2001 Jan;22(1):59-66.</citation>
    <PMID>11085384</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu Z, Boersema GS, Vakalopoulos KA, Daams F, Sparreboom CL, Kleinrensink GJ, Jeekel J, Lange JF. Critical analysis of cyanoacrylate in intestinal and colorectal anastomosis. J Biomed Mater Res B Appl Biomater. 2014 Apr;102(3):635-42. doi: 10.1002/jbm.b.33039. Epub 2013 Oct 24. Review.</citation>
    <PMID>24155114</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colorectal anastomosis</keyword>
  <keyword>leakage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 9, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT03941938/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

